Browsing by Author Lei, Ying

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2008Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerBalleine, Rosemary; Chiew, Yoke-Eng; deFazio, Anna; Guminski, Alexander; Harnett, Paul; Kennedy, Catherine Jane; Lei, Ying; Pryor, Kylie; Rizos, Helen; Scurr, Lyndee; Brand, Alison; Byth, Karen; Sharma, Raghwa; Wain, Gerard V.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer, Clinical Cancer Research, vol.14, 21, 2008,pp 6924-6932
2015The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic functionBrodie, Kirsty Maree; deFazio, Anna; Henderson, Beric; Lei, Ying; Martino-Echarri, Estefania; Marzec, Kamila; Mills, Kate; Mok, Myth; Rizos, Helen; Tembe, Varsha; Boadle, Ross; Kettle, Emma; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Medicine; Western Clinical School: Westmead Institute for Medical Res; Research Grants and Contracts; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResThe BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function, Cellular Signalling, vol.27, 9, 2015,pp 1763-1771
2017EIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomasdeFazio, Anna; Harnett, Paul; Lei, Ying; Moujaber, T; Sharma, Raghwa; Azar, Walid; Chiew, Yoke-Eng; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Garsed, Dale; Hendley, Joy; Kennedy, Catherine; Li, Jason; Mitchell, Chris; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Medicine; Medicine; Medicine; Westmead Clinical School: PathologyEIF1AX and NRAS mutations co-occur and cooperate in low-grade serous ovarian carcinomas, Cancer Research, vol.77, 16, 2017,pp 4268-4278
2015Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosisdeFazio, Anna; Emmanuel, Catherine; Harnett, Paul; Henderson, Beric; Lei, Ying; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; MedicineInhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis, Oncogene, vol.34, 4, 2015,pp 485-495
2008Mitochondrial targeting of adenomatous polyposis coli protein is stimulated by truncating cancer mutations: Regulation of Bcl-2 and implications for cell survivalBrocardo, Mariana; Henderson, Beric; Lei, Ying; Mok, Myth; Taylor, Stephen; Tighe, Anthony; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Medicine; Western Clinical School: Medicine (Westmead)Mitochondrial targeting of adenomatous polyposis coli protein is stimulated by truncating cancer mutations: Regulation of Bcl-2 and implications for cell survival, Journal of Biological Chemistry, vol.283,(9),2008,pp 5950-5959